“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
Is it ethical for scientists to conduct or benefit from research in another country if that research would be unlawful, or not generally accepted, in their own country? In a policy paper in PLoS Medicine Loane Skene, Professor of Law at the University of Melbourne, Australia, presents a unique “barometer” for gauging the ethics of such research.
When it comes to lowering cholesterol levels, garlic stinks, according to a new study from the Stanford University School of Medicine.
The gene Sox17 is discovered to play a central role in the complicated dance of signals, enzymes and proteins that transform embryonic stem cells into a beating heart muscle cell.
Reducing barnyard emissions is one way to help reduce the harmful effects of tiny atmospheric air particles that can cause severe asthma in children, and lung cancer and heart attacks in some adults.
The tiny Drosophila fruit fly may pave the way to new methods for studying and finding treatments for heart disease, the leading cause of death in industrialized countries, according to a collaborative study by the Burnham Institute for Medical Research, UC San Diego (UCSD) and the University of Michigan.
People who smoke have a greater risk of becoming infected with tuberculosis (TB) and of having that infection turn into active TB disease, according to an analysis by researchers at the University of California, Berkeley.
Significant findings have emerged from the California Teachers Study (CTS) that suggest long-term recreational physical activity plays a protective role against invasive and in situ breast cancer.
Researchers at the University of Texas at San Antonio, the University of Texas Health Science Center at San Antonio and the University of Hawaii have found that assisted reproductive technologies do not increase the risk of genetic mutations in developing fetuses.
Dartmouth/VA researchers show that adding CRP testing to routine assessments would increase the number of Americans eligible for cholesterol-lowering treatment by about two million if used judiciously, and by over 25 million if used broadly — with most of these people being at low risk for heart attacks or heart disease.